Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.7 Billion CNY | 7.72% |
| 2022 | 1.57 Billion CNY | -7.95% |
| 2021 | 1.71 Billion CNY | 17.42% |
| 2020 | 1.46 Billion CNY | 174.66% |
| 2019 | 531.87 Million CNY | 10.54% |
| 2018 | 481.15 Million CNY | 110.2% |
| 2017 | 228.9 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.31 Billion CNY | -12.5% |
| 2024 Q1 | 1.5 Billion CNY | -11.69% |
| 2024 Q3 | 1.54 Billion CNY | 17.74% |
| 2023 Q3 | 1.77 Billion CNY | 37.79% |
| 2023 FY | 1.7 Billion CNY | 7.72% |
| 2023 Q4 | 1.7 Billion CNY | -4.45% |
| 2023 Q2 | 1.29 Billion CNY | -14.14% |
| 2023 Q1 | 1.5 Billion CNY | -4.71% |
| 2022 Q3 | 1.69 Billion CNY | -15.12% |
| 2022 Q2 | 1.99 Billion CNY | 17.96% |
| 2022 Q1 | 1.69 Billion CNY | -1.2% |
| 2022 FY | 1.57 Billion CNY | -7.95% |
| 2022 Q4 | 1.57 Billion CNY | -6.95% |
| 2021 Q1 | 1.58 Billion CNY | 8.6% |
| 2021 Q2 | 1.15 Billion CNY | -27.44% |
| 2021 Q4 | 1.71 Billion CNY | -16.21% |
| 2021 Q3 | 2.04 Billion CNY | 77.84% |
| 2021 FY | 1.71 Billion CNY | 17.42% |
| 2020 Q1 | 586.93 Million CNY | 0.0% |
| 2020 FY | 1.46 Billion CNY | 174.66% |
| 2020 Q4 | 1.46 Billion CNY | 0.43% |
| 2020 Q2 | 587.32 Million CNY | 0.07% |
| 2020 Q3 | 1.45 Billion CNY | 147.67% |
| 2019 FY | 531.87 Million CNY | 10.54% |
| 2018 FY | 481.15 Million CNY | 110.2% |
| 2017 FY | 228.9 Million CNY | 0.0% |